AIMS: The aim of this study was to develop a fluorescent reactive oxygen species (ROS) probe, which is preferentially localized in cellular membranes and displays a strong change in fluorescence upon oxidation. We also aimed to test the performance of this probe for detecting pathophysiologically relevant ROS responses in isolated cells. RESULTS: We introduced a novel lipophilic ROS probe dihydrorhodamine B octadecyl ester (H2RB-C18). We then applied the new probe to characterize the ROS changes triggered by inducers of acute pancreatitis in pancreatic acinar cells. We resolved ROS changes produced by L-ornithine, L-arginine, cholecystokinin-8, acetylcholine, taurolithocholic acid 3-sulfate, palmitoleic acid ethyl ester, and the bacterial toxin pyocyanin. Particularly prominent ROS responses were induced by pyocyanin and L-ornithine. These ROS responses were accompanied by changes in cytosolic Ca(2+)concentration ([Ca(2+)]i), mitochondrial membrane potential (ΔΨ), and NAD(P)H concentration. INNOVATION: The study describes a novel sensitive lipophilic ROS probe. The probe is particularly suitable for detecting ROS in near-membrane regions and therefore for reporting the ROS environment of plasma membrane channels and pumps. CONCLUSIONS: In our experimental conditions, the novel probe was more sensitive than 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein (CM-H2DCF) and dihydrorhodamine123 (H2R123) and allowed us to resolve ROS responses to secretagogues, pyocyanin, and L-ornithine. Changes in the fluorescence of the new probe were particularly prominent in the peripheral plasma membrane-associated regions. Our findings suggest that the new probe will be a useful tool in studies of the contribution of ROS to the pathophysiology of exocrine pancreas and other organs/tissues.
AIMS: The aim of this study was to develop a fluorescent reactive oxygen species (ROS) probe, which is preferentially localized in cellular membranes and displays a strong change in fluorescence upon oxidation. We also aimed to test the performance of this probe for detecting pathophysiologically relevant ROS responses in isolated cells. RESULTS: We introduced a novel lipophilic ROS probe dihydrorhodamine B octadecyl ester (H2RB-C18). We then applied the new probe to characterize the ROS changes triggered by inducers of acute pancreatitis in pancreatic acinar cells. We resolved ROS changes produced by L-ornithine, L-arginine, cholecystokinin-8, acetylcholine, taurolithocholic acid 3-sulfate, palmitoleic acid ethyl ester, and the bacterial toxin pyocyanin. Particularly prominent ROS responses were induced by pyocyanin and L-ornithine. These ROS responses were accompanied by changes in cytosolic Ca(2+)concentration ([Ca(2+)]i), mitochondrial membrane potential (ΔΨ), and NAD(P)H concentration. INNOVATION: The study describes a novel sensitive lipophilic ROS probe. The probe is particularly suitable for detecting ROS in near-membrane regions and therefore for reporting the ROS environment of plasma membrane channels and pumps. CONCLUSIONS: In our experimental conditions, the novel probe was more sensitive than 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein (CM-H2DCF) and dihydrorhodamine123 (H2R123) and allowed us to resolve ROS responses to secretagogues, pyocyanin, and L-ornithine. Changes in the fluorescence of the new probe were particularly prominent in the peripheral plasma membrane-associated regions. Our findings suggest that the new probe will be a useful tool in studies of the contribution of ROS to the pathophysiology of exocrine pancreas and other organs/tissues.
Authors: Nick J Dolman; Julia V Gerasimenko; Oleg V Gerasimenko; Svetlana G Voronina; Ole H Petersen; Alexei V Tepikin Journal: J Biol Chem Date: 2005-02-18 Impact factor: 5.157
Authors: Sarahjayne Boulton; Alasdair Anderson; Helen Swalwell; James R Henderson; Philip Manning; Mark A Birch-Machin Journal: Free Radic Res Date: 2010-10-13
Authors: Svetlana G Voronina; Stephanie L Barrow; Oleg V Gerasimenko; Ole H Petersen; Alexei V Tepikin Journal: J Biol Chem Date: 2004-04-14 Impact factor: 5.157
Authors: Gyorgy Lur; Lee P Haynes; Ian A Prior; Oleg V Gerasimenko; Stefan Feske; Ole H Petersen; Robert D Burgoyne; Alexei V Tepikin Journal: Curr Biol Date: 2009-09-17 Impact factor: 10.834
Authors: Wei Huang; Nicole Cash; Li Wen; Peter Szatmary; Rajarshi Mukherjee; Jane Armstrong; Michael Chvanov; Alexei V Tepikin; Michael P Murphy; Robert Sutton; David N Criddle Journal: Mediators Inflamm Date: 2015-03-23 Impact factor: 4.711
Authors: Antonella Managò; Katrin Anne Becker; Alexander Carpinteiro; Barbara Wilker; Matthias Soddemann; Aaron P Seitz; Michael J Edwards; Heike Grassmé; Ildiko Szabò; Erich Gulbins Journal: Antioxid Redox Signal Date: 2015-03-18 Impact factor: 8.401
Authors: Jane A Armstrong; Nicole J Cash; Jack C Morton; Alexei V Tepikin; Robert Sutton; David N Criddle Journal: Int J Mol Sci Date: 2019-04-05 Impact factor: 5.923
Authors: Xiaoying Zhang; Tao Jin; Na Shi; Linbo Yao; Xinmin Yang; Chenxia Han; Li Wen; Dan Du; Peter Szatmary; Rajarshi Mukherjee; Tingting Liu; Qing Xia; David N Criddle; Wei Huang; Michael Chvanov; Robert Sutton Journal: Front Physiol Date: 2019-01-15 Impact factor: 4.566
Authors: Fruzsina R Walter; András Harazin; Andrea E Tóth; Szilvia Veszelka; Ana R Santa-Maria; Lilla Barna; András Kincses; György Biczó; Zsolt Balla; Balázs Kui; József Maléth; László Cervenak; Vilmos Tubak; Ágnes Kittel; Zoltán Rakonczay; Mária A Deli Journal: Fluids Barriers CNS Date: 2022-02-17
Authors: Michael Chvanov; Francesca De Faveri; Danielle Moore; Mark W Sherwood; Muhammad Awais; Svetlana Voronina; Robert Sutton; David N Criddle; Lee Haynes; Alexei V Tepikin Journal: J Physiol Date: 2018-06-06 Impact factor: 5.182
Authors: Francesca De Faveri; Michael Chvanov; Svetlana Voronina; Danielle Moore; Liam Pollock; Lee Haynes; Muhammad Awais; Alison J Beckett; Ulrike Mayer; Robert Sutton; David N Criddle; Ian A Prior; Tom Wileman; Alexei V Tepikin Journal: Autophagy Date: 2019-10-25 Impact factor: 16.016